323990.KQ
Vaxcell-Bio Therapeutics Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 4,490.00
−10.56%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.08x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.11x
- Net debt / EBITDA
- 0.30x
Liquidity & coverage
- Current ratio
- 5.56x
- Quick ratio
- 5.46x
- Cash ratio
- 4.23x
- Interest coverage
- -85.01x
- EBITDA / interest
- -68.37x
- Working capital
- KRW 16.0B
Cash & dividend
- FCF / debt
- -11.53x
- Cash flow / debt
- -6.82x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026